SCHEMBL31281965

SCHEMBL31281965

Cn1c(=O)n(C2CCCNC2)c2ccc(CN3CCN(C4CCNCC4)CC3)cc21

nearest known ligand 0.39

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 1/20 0.39
▸ SLC6A4 P31645 1/20 0.39
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ TRPV6 Q9H1D0 5/20 0.37
▸ DDB1 Q16531 2/20 0.37
▸ CRBN Q96SW2 2/20 0.37
▸ CYP3A4 P08684 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ PARP1 P09874 1/20 0.35
▸ PARP2 Q9UGN5 1/20 0.35
▸ GNRHR P30968 1/20 0.35
▸ CTSS P25774 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31282081 0.92 DRD2 (0.44) DRD2SLC6A4DDB1CRBNCYP3A4
SCHEMBL31282708 0.89 DRD2 (0.42) DRD2SLC6A4DDB1CRBNCYP3A4
SCHEMBL31281909 0.88 DRD2 (0.41) DRD2SLC6A4DDB1CRBNCYP3A4
SCHEMBL31282427 0.88 DRD2 (0.41) DRD2SLC6A4DDB1CRBNCYP3A4
SCHEMBL31282370 0.87 DRD2 (0.40) DRD2SLC6A4DDB1CRBNCYP3A4
SCHEMBL31282451 0.86 DRD2 (0.37) DRD2SLC6A4DDB1CRBNALDH1A1
SCHEMBL31282093 0.84 DRD2 (0.38) DRD2SLC6A4DDB1CRBNCYP3A4
SCHEMBL31281914 0.84 DRD2 (0.38) DRD2SLC6A4DDB1CRBNCYP3A4
SCHEMBL31282557 0.83 DRD2 (0.36) DRD2SLC6A4DDB1CRBNCYP3A4
SCHEMBL30798793 0.83 DRD2 (0.39) DRD2SLC6A4DDB1CRBNCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4731309-A1 KRAS PROTEOLYSIS TARGETING CHIMERAS Paq Therapeutics Inc. (US) 2026-04-29 — — EP disclosed
WO-2024263586-A1 KRAS PROTEOLYSIS TARGETING CHIMERAS PAQ Therapeutics Inc. (US) 2024-12-26 — — WO disclosed
Send feedback